Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of the body.Nasal steroids, or corticosteroids, are highly effective at reducing inflammation, especially that caused by allergiesNasal steroids are sprayed or inhaled into the nose to help relieve nasal and sinus congestion, excessive mucus production, and nasal inflammation caused by conditions such as hay fever or allergic rhinitis or other allergies, and other nasal problems.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=43403Key Drivers and Restraints of Global Nasal Steroids MarketIncrease in the prevalence of allergic rhinitis, along with inflammation of the nose, especially among geriatric people, is a major factor fueling the global nasal steroid marketAccording to American Academy of Allergy, Asthma & Immunology (AAAAI), approximately 10 to 30% of adults and 40% of children are affected by allergic rhinitis worldwideAccording to the World Health Organization (WHO), the population of people aged 60 years and above is projected to rise from 900 million in 2015 to 2 billion by 2050.
Hence, an increase in the geriatric population is anticipated to boost the global nasal steroids market.Nasal steroids are a better alternative to other drugs for nasal swelling and congestion.
This is estimated to boost the nasal steroid market during the forecast period.Request COVID Analysis on Nasal Steroids Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=43403According to the International Study on Asthma and Allergies in Childhood, prevalence of allergic rhinitis in the age group of 6 to 7 years in places such as Australia, New Zealand, and the U.K. is increasing and is projected to drive the nasal steroid market during the forecast periodIncrease in government support and initiatives for clinical research & development and consumption of nasal steroids is projected to fuel the market during the forecast period.
For instance, there has been a call for rise in production capacity of budesonide nasal spray, which shortens the COVID19 recovery time.However, certain side-effects associated with the drugs such as nosebleed, sore throat, cough, nose dryness, etc., are likely to hamper the nasal steroid market in the next few yearsRequest Customization on Nasal Steroids Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=43403North America to Dominate MarketIn terms of region, the global nasal steroids market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & AfricaNorth America dominates the global market.
Additionally, according to the American Academy of Allergy, Asthma, and Immunology, every year, approximately 30 to 60 million people in the U.S. are affected with allergic rhinitis.In Europe, according to a report of the European Academy of Allergy and Clinical Immunology published in 2017, almost 100 million people in Europe suffer from allergic rhinitis, and the disease is increasing among the geriatric population.
Moreover, according to a survey report of the European Community Respiratory Health Survey (ECRHS) for the adult population in Europe, it was found that the overall prevalence of allergic rhinitis was 21% among all the respiration diseases.
